Joel A. Krauser

Papers

Total Citations

H-Index

About

Joel A. Krauser is a leading figure in drug metabolism and radiochemistry, whose work has fundamentally advanced the detection and characterization of drug metabolites during pharmaceutical development. His primary research focuses on the design and application of innovative automation platforms for measuring low-level radioactivity, specifically targeting the challenges of metabolite identification in complex biological matrices. Krauser’s major contribution lies in pioneering high-sensitivity radio-detection systems that enable the precise profiling of radiolabeled compounds (e.g., ¹⁴C or ³H), allowing researchers to define metabolic pathways and elucidate metabolite structures with unprecedented accuracy. His seminal 2012 paper, "A Unique Automation Platform for Measuring Low Level Radioactivity in Metabolite Identification Studies," has garnered 5 citations and remains a foundational reference for integrating automation into biotransformation studies. By streamlining the generation and interpretation of critical metabolic data, Krauser’s work has directly supported safer, more effective drug development, ensuring that physiologically relevant metabolites are identified early in the pipeline. His contributions continue to shape best practices in radiochemical analysis and metabolite safety assessment.